Summary:
«C2i Genomics plans to make sophisticated AI-informed cancer diagnostics and tumor monitoring available throughout the world, regardless of where patients or clinical trials are located.»
Article written by Gail Dutton. Photo by C2i Genomics.
25|10|2021
Source:
BioSpace
https://www.biospace.com/article/c2i-genomics-is-globalizing-ai-based-cancer-diagnostics-and-monitoring-/?s=89